Susquehanna International Group’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-16,000
| Closed | -$1.28M | – | 13678 |
|
|
2021
Q1 | $1.28M | Buy |
+16,000
| New | +$1.25M | ﹤0.01% | 7075 |
|
|
2020
Q4 | – | Sell |
-80,300
| Closed | -$3.53M | – | 12011 |
|
|
2020
Q3 | $3.53M | Buy |
80,300
+43,500
| +118% | +$2.14M | ﹤0.01% | 3594 |
|
|
2020
Q2 | $1.63M | Buy |
36,800
+17,800
| +94% | +$664K | ﹤0.01% | 4869 |
|
|
2020
Q1 | $682K | Sell |
19,000
-57,900
| -75% | -$3.29M | ﹤0.01% | 6262 |
|
|
2019
Q4 | $5.45M | Buy |
76,900
+66,900
| +669% | +$4.85M | ﹤0.01% | 2866 |
|
|
2019
Q3 | $748K | Sell |
10,000
-6,300
| -39% | -$534K | ﹤0.01% | 6358 |
|
|
2019
Q2 | $1.31M | Buy |
16,300
+10,200
| +167% | +$717K | ﹤0.01% | 5080 |
|
|
2019
Q1 | $408K | Buy |
6,100
+2,100
| +53% | +$159K | ﹤0.01% | 6662 |
|
|
2018
Q4 | $298K | Sell |
4,000
-1,700
| -30% | -$140K | ﹤0.01% | 7019 |
|
|
2018
Q3 | $525K | Sell |
5,700
-29,600
| -84% | -$2.82M | ﹤0.01% | 6424 |
|
|
2018
Q2 | $3.47M | Buy |
35,300
+26,200
| +288% | +$2.93M | ﹤0.01% | 3188 |
|
|
2018
Q1 | $1.01M | Buy |
9,100
+5,600
| +160% | +$628K | ﹤0.01% | 5218 |
|
|
2017
Q4 | $360K | Sell |
3,500
-51,500
| -94% | -$5.13M | ﹤0.01% | 7259 |
|
|
2017
Q3 | $5.18M | Buy |
+55,000
| New | +$4.34M | ﹤0.01% | 2456 |
|
|
2017
Q2 | – | Sell |
-2,800
| Closed | -$224K | – | 10103 |
|
|
2017
Q1 | $224K | Sell |
2,800
-900
| -24% | -$71.5K | ﹤0.01% | 7852 |
|
|
2016
Q4 | $291K | Buy |
+3,700
| New | +$288K | ﹤0.01% | 8039 |
|
Susquehanna International Group's CMD Position: Q2 2021 in Review
Susquehanna International Group sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 6,389 shares — an estimated $510K sold.
Susquehanna International Group first reported a position in CMD in Q2 2013 and held it in 27 quarters. The position peaked at $9.48M in Q2 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Susquehanna International Group reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Susquehanna International Group sold 6,389 Cantel Medical Corporation shares in Q2 2021, an estimated $510K.
- Susquehanna International Group first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 27 quarters.
- Susquehanna International Group's Cantel Medical Corporation position peaked at $9.48M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.